Matteo Sturla Profile
Matteo Sturla

@MatteoSturlaM

Followers
157
Following
544
Media
6
Statuses
91

@MontefioreIM / @EinsteinMed | MD @HUNIMED @HumanitasMilano | Aspiring interventional cardiologist

Joined March 2020
Don't wanna be here? Send us removal request.
@jcecharte
Julio Echarte
4 months
💫Thrilled to present at #NYValves2025 the results on the impact of extra-tricuspid valve damage in patients managed conservatively or with T-TEER. Thanks to the huge effort of the #BronxValve and #TRISPA investigators. @RodrigoEstvez1 @azeemlatib
2
11
58
@crfheart
Cardiovascular Research Foundation
4 months
🫀 New updates in #tricuspid therapies coming up at #NYValves2025! Don't miss late-breaking trials on TEER, TTVR, patient outcomes, and real-world registries. @LindaGillamMD @matthewjpricemd @p_grayburn @arnoldgehrke @LindenfeldJoann @jcecharte @J_hausleiter #CardioResearch
0
3
15
@UlrichJordeMD
Ulrich Jorde
4 months
Deep dive into amyloid & sarcoid happening now #MonteHeart2025 🔬🫀@yogitar @aschenonegiugni Valvular therapies in HF coming up soon ⏰ @AndreaScotti21 @leoneppmd @EdwinHoMD @m_assafin 🔗 https://t.co/deZSJMiyfu 🔗 https://t.co/Wd3KgcZA5I
0
7
26
@jcecharte
Julio Echarte
5 months
🎯 Our Structural Team performed 2 TMVR cases with the #AltaValve system #🗺️ Atlas Trial ➡️ Atrial Fixation system ⤵️ LVOTO ✅ Abolished MR @RodrigoEstvez1 @manuelbarreirop @jabazal
0
5
18
@jtorrado_arrosa
Juan Torrado, MD, PhD
7 months
Severe TR in a Patient With a CIED: What We Have Learned | JACC: Case Reports @azeemlatib⁩ ⁦@jcecharte⁩ ⁦⁦@MatteoSturlaM@AndreaScotti21⁩ ⁦@leoneppmd⁩ ⁦⁦⁦⁦@EdwinHoMD⁩ ⁦⁦@elie_flatow⁩ ⁦@GrushkoMichael
Tweet card summary image
jacc.org
3
4
18
@crfheart
Cardiovascular Research Foundation
8 months
#CTO2025 starts tomorrow in NYC! There’s still time to register. ⏳ Are you ready to master CTO and complex PCI alongside the world’s top operators? Don’t miss out on live cases, real-time expert analysis, and deep dives into the latest science and technology. 🔥 Secure your
1
5
17
@crfheart
Cardiovascular Research Foundation
8 months
#CTO2025 kicks off this Friday! Are you in? It’s not too late to join the premier CTO and Complex PCI course! Witness the world’s top operators tackle some of the most challenging live cases with precision and expertise. ⏳ Short on time? One-day access lets you pick your
0
9
16
@MatteoSturlaM
Matteo Sturla
8 months
Less than a week to go until #CTO2025 in NYC! 🗽 Excited to learn from a stellar lineup of cardiology experts and dive into groundbreaking sessions! 🤩 Explore the program guide and mark your calendars: https://t.co/PCQipvXwG5
1
2
5
@crfheart
Cardiovascular Research Foundation
8 months
🚀 #CTO2025: Where Innovation Meets Expertise! 💡 Get ready to explore the future of CTO and complex PCI with live cases, moderated abstracts, and expert debates featuring the world’s top interventionalists! 🌍✨ Explore the full program guide and plan your experience:
0
9
21
@crfheart
Cardiovascular Research Foundation
8 months
🚨 #CTO2025 is NEXT WEEK! Get ready for an unforgettable 2-day experience! Join us as we dive into CTO and complex PCI with the world’s top experts. 🌎 🔑 Gain invaluable insights, discover innovative strategies, and elevate your expertise to take your practice to new heights!
0
9
15
@AndreaScotti21
Andrea Scotti
8 months
✨ TRANSCATHETER VALVE REPLACEMENT: Valve Selection and Lifetime Management ✨ 📖 Thrilled to announce the release of this cutting-edge, up-to-date 2025 resource – co-edited by me and @azeemlatib 🔗 Explore the book here: https://t.co/1958Gtb4rb @MontefioreNYC @EinsteinMed
3
23
71
@crfheart
Cardiovascular Research Foundation
8 months
⏳Short on time? No problem! Get one-day access to #CTO2025 and stay at the forefront of CTO and high-risk PCI. 🚀 Learn from top experts, explore the latest breakthroughs, and elevate your expertise — all in just one day! Register now: https://t.co/hWbuG0vLhs   #CardioX
0
6
10
@JAHA_AHA
JAHA
9 months
The Bronx‐Valve Registry reveals striking racial and ethnic disparities in valvular heart disease. #AHAJournals @AndreaScotti21 @MatteoSturlaM @azeemlatib @MonteHeart https://t.co/hMnKvkFQsk
0
4
11
@MatteoSturlaM
Matteo Sturla
9 months
We hope Bronx Valve sheds light on disparities in VHD and drives better representation in future clinical trials where diversity has historically been lacking. Very proud to serve such a diverse population in the Bronx @azeemlatib @AndreaScotti21 @jcecharte @leoneppmd @MonteHeart
@AndreaScotti21
Andrea Scotti
9 months
🌐Burden of Valvular Heart Diseases in a Diverse Population: The Bronx Valve Registry 🎯There is a clear need for more DIVERSE participation in clinical trials 🔗 https://t.co/WgcecX6DAS @azeemlatib @MatteoMSturla @jcecharte @MonteHeart @MontefioreNYC @EinsteinMed @JAHA_AHA
0
4
15
@jcecharte
Julio Echarte
10 months
💫Check our last paper from @MonteHeart based on Race/Ethnicity disparities in severe TR @azeemlatib @AndreaScotti21 @guilbon @jtorrado_arrosa @MatteoSturlaM 🎯 Black/Hispanic ➡️advanced TR disease 🎯 A-STR ⬆️ in White ➡️ Black experienced ⬆️HF 🏥 📎 https://t.co/WZJxebkFhz
1
9
23
@leoneppmd
Pier Pasquale Leone
10 months
What a Wednesday at @MonteHeart! 🥇case of AltaValve in New York 🥇case enrolled in TRINITY EFS study with Lux-Valve Plus Fantastic to be part of this terrific Team @azeemlatib @jgranadacrf @modine_thomas @EdwinHoMD @m_assafin Tadahisa Sugiura @AndreaScotti21 @MatteoSturlaM
1
7
39
@MatteoSturlaM
Matteo Sturla
11 months
Check out our case series of hemolytic anemia post TAVR. We demonstrate a feasible and effective percutaneous approach for these patients. Great team effort @AndreaScotti21 @Antonellamillin @jcecharte @guilbon @andrea_mignatti @m_assafin @CardioMDPhD @EdwinHoMD @azeemlatib
@CurioJonathan
Jonathan Curio
11 months
Very educative & nicely illustrated series on #TAVR #PVL + hemolysis by @MonteHeart team in @JACCJournals #JACCCR 🎯Distinct clinical presentations ➡️Plug based closure ➡️Resolution of hemolysis at f/u 🔗: https://t.co/vbc6497i3Z
0
3
15
@guilbon
Guillaume Bonnet
11 months
🚀 Innovation alert at #PCRLV 2024! Abbott unveils a new balloon-expandable aortic valve replacement platform 🫀. The first-in-human case has been performed—a promising step forward! While further data are needed, this highlights the dynamic evolution of the aortic field, full
0
4
19